Search results for "Vaccination"


 
Results 91 - 100 of about 510 for "Vaccination".
Sort by: Relevance | Newest | Oldest

Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare

A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021

New authorization, guidance on vaccines against SARS-CoV-2

The Moderna COVID-19 vaccine was authorized by the FDA and recommended by the CDC, additional guidance was issued on the use of the Pfizer-BioNTech vaccine, and ACP and Annals of Internal Medicine held a forum on encouraging vaccine uptake.
https://immattersacp.org/weekly/archives/2020/12/22/1.htm
22 Dec 2020

Transforming health care to improve U.S. life expectancy

The sobering decline in U.S. life expectancy reaffirms the exigency of health care reform anchored in a proactive and comprehensive approach.
https://immattersacp.org/archives/2023/10/transforming-health-care-to-improve-us-life-expectancy.htm
1 Oct 2023

Q&A with ACP's President on COVID-19 vaccines

George M. Abraham, MD, MPH, MACP, ACP's President, recently discussed the difference between third shots and boosters and other complexities of vaccination, as well as offered advice to internists on getting more patients vaccinated.
https://immattersacp.org/weekly/archives/2021/11/23/1.htm
23 Nov 2021

Progress and limitations on vaccines, strokes and readmissions in COVID-19

A report warned that a few health care workers developed COVID-19 shortly after vaccination, and studies showed that strokes were rare in COVID-19 patients but readmissions could not be predicted easily.
https://immattersacp.org/weekly/archives/2021/02/09/1.htm
9 Feb 2021

The waning and boosting of COVID-19 immunity

ACP and Annals of Internal Medicine's sixth COVID-19 forum examined progress amid the pandemic in the past year.
https://immattersacp.org/archives/2021/11/the-waning-and-boosting-of-covid-19-immunity.htm
1 Nov 2021

New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions

A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022

Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines

Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://immattersacp.org/weekly/archives/2020/10/20/2.htm
20 Oct 2020

New vaccine authorization and data, NIH on antibody treatment and ‘long COVID’

The Johnson & Johnson COVID-19 vaccine got an emergency use authorization, and an Israeli study provided more data on the Pfizer vaccine. The NIH recommended an antibody combo for outpatients and named long-term symptoms as post-acute sequelae of SARS-CoV-2 (PASC).
https://immattersacp.org/weekly/archives/2021/03/02/1.htm
2 Mar 2021

Research on COVID-19 vaccines' duration, reactions, prioritization

Antibodies persisted six months after vaccination, and a graded dosing protocol allowed patients with reactions to a first shot to get a second. Surveyed Americans wanted to prioritize front-line workers and those with chronic conditions for vaccination, and a columnist finds reasons for hope.
https://immattersacp.org/weekly/archives/2021/04/13/1.htm
13 Apr 2021

Result Page: Prev   5   6   7   8   9   10   11   12   13   14   Next